Lars Wramner

2.4k total citations · 1 hit paper
39 papers, 1.9k citations indexed

About

Lars Wramner is a scholar working on Transplantation, Surgery and Nephrology. According to data from OpenAlex, Lars Wramner has authored 39 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Transplantation, 16 papers in Surgery and 10 papers in Nephrology. Recurrent topics in Lars Wramner's work include Renal Transplantation Outcomes and Treatments (21 papers), Organ Transplantation Techniques and Outcomes (11 papers) and Renal Diseases and Glomerulopathies (8 papers). Lars Wramner is often cited by papers focused on Renal Transplantation Outcomes and Treatments (21 papers), Organ Transplantation Techniques and Outcomes (11 papers) and Renal Diseases and Glomerulopathies (8 papers). Lars Wramner collaborates with scholars based in Sweden, Vietnam and France. Lars Wramner's co-authors include Josep M. Campistol, Henri Kreis, D. Durand, Carl G. Groth, C Brattström, Lars Bäckman, Kerstin Claesson, Philippe Lang, Jean-Louis Touraine and Roy Calne and has published in prestigious journals such as PLoS ONE, Kidney International and Transplantation.

In The Last Decade

Lars Wramner

38 papers receiving 1.8k citations

Hit Papers

SIROLIMUS (RAPAMYCIN)-BASED THERAPY IN HUMAN RENAL TRANSP... 1999 2026 2008 2017 1999 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. SIROLIMUS (RAPAMYCIN)-BASED THERAPY IN HUMAN RENAL TRANSPLANTATION
    1999 700 citations Carl G. Groth, Lars Bäckman et al. Transplantation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lars Wramner Sweden 14 1.3k 878 372 279 248 39 1.9k
James T. Burke Spain 14 1.4k 1.1× 880 1.0× 432 1.2× 252 0.9× 172 0.7× 16 2.0k
Stephen M. Katz United States 21 1.2k 0.9× 789 0.9× 228 0.6× 243 0.9× 132 0.5× 60 1.7k
David A. Laskow United States 21 1.1k 0.9× 753 0.9× 251 0.7× 360 1.3× 341 1.4× 50 2.1k
Kerstin Claesson Sweden 22 1.8k 1.4× 1.4k 1.6× 610 1.6× 308 1.1× 159 0.6× 52 2.8k
L. Mjörnstedt Sweden 19 771 0.6× 796 0.9× 131 0.4× 249 0.9× 137 0.6× 79 1.4k
Antonio Schena Italy 18 716 0.6× 464 0.5× 166 0.4× 263 0.9× 167 0.7× 43 1.8k
Yoshihiko Watarai Japan 21 799 0.6× 570 0.6× 132 0.4× 194 0.7× 401 1.6× 141 1.6k
Miguel Hueso Spain 20 883 0.7× 593 0.7× 151 0.4× 235 0.8× 290 1.2× 61 1.4k
Stéphan Busque United States 27 1.4k 1.1× 1.1k 1.2× 136 0.4× 667 2.4× 318 1.3× 69 2.6k
Jon Ross United States 14 521 0.4× 507 0.6× 175 0.5× 130 0.5× 182 0.7× 21 2.3k

Countries citing papers authored by Lars Wramner

Since Specialization
Citations

This map shows the geographic impact of Lars Wramner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Wramner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Wramner more than expected).

Fields of papers citing papers by Lars Wramner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lars Wramner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Wramner. The network helps show where Lars Wramner may publish in the future.

Co-authorship network of co-authors of Lars Wramner

This figure shows the co-authorship network connecting the top 25 collaborators of Lars Wramner. A scholar is included among the top collaborators of Lars Wramner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lars Wramner. Lars Wramner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vuong, Mai Tuyet, Sigrid Lundberg, Iva Gunnarsson, et al.. (2013). Genetic evidence for involvement of adaptive immunity in the development of IgA nephropathy: MHC class II alleles are protective in a Caucasian population. Human Immunology. 74(8). 957–960. 3 indexed citations
2.
3.
Vuong, Mai Tuyet, Mirjana Hahn‐Zoric, Sigrid Lundberg, et al.. (2010). Association of soluble CD89 levels with disease progression but not susceptibility in IgA nephropathy. Kidney International. 78(12). 1281–1287. 70 indexed citations
4.
Vuong, Mai Tuyet, Sigrid Lundberg, Iva Gunnarsson, et al.. (2009). Genetic variation in the transforming growth factor- 1 gene is associated with susceptibility to IgA nephropathy. Nephrology Dialysis Transplantation. 24(10). 3061–3067. 25 indexed citations
5.
Fehrman‐Ekholm, Ingela, Gunnela Nordén, Annette Lennerling, et al.. (2006). Incidence of End-Stage Renal Disease Among Live Kidney Donors. Transplantation. 82(12). 1646–1648. 108 indexed citations
6.
Nordén, Gunnela, et al.. (2004). Macrovascular disease after simultaneous pancreas and kidney transplantation. Clinical Transplantation. 18(4). 372–376. 10 indexed citations
7.
Charpentier, B, C. G. Groth, Lars Bäckman, et al.. (2003). Bicêtre hospital experience with sirolimus-based therapy in human renal transplantation: the sirolimus European renal transplant study. Transplantation Proceedings. 35(3). S58–S61. 24 indexed citations
8.
Morales, J.M., Lars Wramner, Henri Kreis, et al.. (2002). Sirolimus Does Not Exhibit Nephrotoxicity Compared to Cyclosporine in Renal Transplant Recipients. American Journal of Transplantation. 2(5). 436–442. 163 indexed citations
9.
Herlenius, Gustaf, S. Friman, Lars Bäckman, et al.. (2002). Initial experience with multivisceral, cluster, and combined liver and small bowel transplantation in Sweden. Transplantation Proceedings. 34(3). 865–865. 1 indexed citations
10.
Kreis, Henri, Jean‐Marc Cisterne, W. Land, et al.. (2000). SIROLIMUS IN ASSOCIATION WITH MYCOPHENOLATE MOFETIL INDUCTION FOR THE PREVENTION OF ACUTE GRAFT REJECTION IN RENAL ALLOGRAFT RECIPIENTS12. Transplantation. 69(7). 1252–1260. 456 indexed citations
11.
Groth, Carl G., Lars Bäckman, Roy Calne, et al.. (1999). SIROLIMUS (RAPAMYCIN)-BASED THERAPY IN HUMAN RENAL TRANSPLANTATION. Transplantation. 67(7). 1036–1042. 700 indexed citations breakdown →
12.
13.
Olausson, Michael, I Blohmé, Ludvig J. Backman, et al.. (1997). Experience from a single institution: 3000 consecutive kidney transplants during 30 years. Transplantation Proceedings. 29(7). 3096–3097. 1 indexed citations
14.
Olausson, Michael, Lars Wramner, I Blohmé, & L. Mjörnstedt. (1997). Heart allograft rejection in rats triggered by H2 inhibitors. Transplantation Proceedings. 29(7). 3127–3128. 1 indexed citations
15.
Wramner, Lars, L. Mjörnstedt, I Blohmé, et al.. (1995). Alterations of the Post Transplant Blood Lymphocyte Phenotype Subsets as a Marker of Rejection in Renal Allograft Recipients. Scandinavian Journal of Immunology. 42(2). 275–281. 4 indexed citations
16.
Olausson, Michael, et al.. (1993). Alteration in T Cell Subset Phenotypes as Cell Markers for Rejection or Long-Term Allograft Acceptance in Allografted Rats Treated with Antithymocyte Globulin. International Archives of Allergy and Immunology. 101(4). 431–436. 11 indexed citations
17.
Wramner, Lars, L. Mjörnstedt, Lennart Rydberg, & Michael Olausson. (1993). Cell‐Mediated Immune Responses in Renal Transplant Recipients treated with Cyclosporin and Prednisolone with or without Azathioprine. Scandinavian Journal of Immunology. 37(6). 656–660. 8 indexed citations
18.
Olausson, Michael, L. Mjörnstedt, Lars Wramner, et al.. (1992). Adjuvant treatment with ursodeoxycholic acid prevents acute rejection in rats receiving heart allografts. PubMed. 5 Suppl 1. 539–541. 6 indexed citations
19.
Wramner, Lars, et al.. (1990). Blood lymphocyte subsets in ATG-treated and allografted rats. Transplant International. 3(2). 55–58. 2 indexed citations
20.
Olausson, Michael, L. Mjörnstedt, Lars Wramner, et al.. (1988). Characteristics of the Induction Phase of Antithymocyte-Globulin-Induced Heart Allograft Tolerance in the Rat. International Archives of Allergy and Immunology. 86(2). 131–138. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by James T. Burke Breakdown of academic impact, for papers by Stephen M. Katz Breakdown of academic impact, for papers by David A. Laskow Breakdown of academic impact, for papers by Kerstin Claesson Breakdown of academic impact, for papers by L. Mjörnstedt Breakdown of academic impact, for papers by Antonio Schena Breakdown of academic impact, for papers by Yoshihiko Watarai Breakdown of academic impact, for papers by Miguel Hueso Breakdown of academic impact, for papers by Stéphan Busque Breakdown of academic impact, for papers by Jon Ross
Rankless by CCL
2026